French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
Copyright © 2020. Published by Elsevier Masson SAS..
Tracheostomy post-tracheostomy care are regarded as at high risk for contamination of health care professionals with the new coronavirus (SARS-CoV-2). Considering the rapid spread of the infection, all patients in France must be considered as potentially infected by the virus. Nevertheless, patients without clinical or radiological (CT scan) markers of COVID-19, and with negative nasopharyngeal sample within 24h of surgery, are at low risk of being infected. Instructions for personal protection include specific wound dressings and decontamination of all material used. The operating room should be ventilated after each tracheostomy and the pressure of the room should be neutral or negative. Percutaneous tracheostomy is to be preferred over surgical cervicotomy in order to reduce aerosolization and to avoid moving patients from the intensive care unit to the operating room. Ventilation must be optimized during the procedure, to limit patient oxygen desaturation. Drug assisted neuromuscular blockage is advised to reduce coughing during tracheostomy tube insertion. An experienced team is mandatory to secure and accelerate the procedure as well as to reduce risk of contamination.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:137 |
|---|---|
| Enthalten in: |
European annals of otorhinolaryngology, head and neck diseases - 137(2020), 3 vom: 01. Mai, Seite 167-169 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schultz, P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 22.05.2020 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anorl.2020.04.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308920414 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308920414 | ||
| 003 | DE-627 | ||
| 005 | 20231225132758.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anorl.2020.04.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1029.xml |
| 035 | |a (DE-627)NLM308920414 | ||
| 035 | |a (NLM)32307265 | ||
| 035 | |a (PII)S1879-7296(20)30096-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schultz, P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.05.2020 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020. Published by Elsevier Masson SAS. | ||
| 520 | |a Tracheostomy post-tracheostomy care are regarded as at high risk for contamination of health care professionals with the new coronavirus (SARS-CoV-2). Considering the rapid spread of the infection, all patients in France must be considered as potentially infected by the virus. Nevertheless, patients without clinical or radiological (CT scan) markers of COVID-19, and with negative nasopharyngeal sample within 24h of surgery, are at low risk of being infected. Instructions for personal protection include specific wound dressings and decontamination of all material used. The operating room should be ventilated after each tracheostomy and the pressure of the room should be neutral or negative. Percutaneous tracheostomy is to be preferred over surgical cervicotomy in order to reduce aerosolization and to avoid moving patients from the intensive care unit to the operating room. Ventilation must be optimized during the procedure, to limit patient oxygen desaturation. Drug assisted neuromuscular blockage is advised to reduce coughing during tracheostomy tube insertion. An experienced team is mandatory to secure and accelerate the procedure as well as to reduce risk of contamination | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Care | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a Percutaneous | |
| 650 | 4 | |a SARS-Cov-2 | |
| 650 | 4 | |a Tracheostomy | |
| 700 | 1 | |a Morvan, J-B |e verfasserin |4 aut | |
| 700 | 1 | |a Fakhry, N |e verfasserin |4 aut | |
| 700 | 1 | |a Morinière, S |e verfasserin |4 aut | |
| 700 | 1 | |a Vergez, S |e verfasserin |4 aut | |
| 700 | 1 | |a Lacroix, C |e verfasserin |4 aut | |
| 700 | 1 | |a Bartier, S |e verfasserin |4 aut | |
| 700 | 1 | |a Barry, B |e verfasserin |4 aut | |
| 700 | 1 | |a Babin, E |e verfasserin |4 aut | |
| 700 | 1 | |a Couloigner, V |e verfasserin |4 aut | |
| 700 | 1 | |a Atallah, I |e verfasserin |4 aut | |
| 700 | 0 | |a French Society of Otorhinolaryngology, Head, Neck Surgery (SFORL) |e verfasserin |4 aut | |
| 700 | 0 | |a French Society of Head, Neck Carcinology (SFCCF) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European annals of otorhinolaryngology, head and neck diseases |d 2010 |g 137(2020), 3 vom: 01. Mai, Seite 167-169 |w (DE-627)NLM201398648 |x 1879-730X |7 nnns |
| 773 | 1 | 8 | |g volume:137 |g year:2020 |g number:3 |g day:01 |g month:05 |g pages:167-169 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anorl.2020.04.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 137 |j 2020 |e 3 |b 01 |c 05 |h 167-169 | ||